News

2009-07-11 - ICAD Conference News & updates

ICAD studies we will be reporting on include the results of two large studies examining the impact of docosahexanoic acid (DHA), an Omega-3 fatty acid found in fish and algae, on Alzheimer's and cognitive performance. In addition to therapy trials, results from a broad range of studies will be presented at ICAD 2009, including:

• Surprising results from two large studies on the increasing prevalence and incidence of Alzheimer's in the "oldest old" (people over 80).
• Several studies using new data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) advance our knowledge of possible biomarkers -- including imaging technologies and substances in blood and CSF -- for early detection of Alzheimer's and for improved testing of therapies.
• New data from professionals who conduct Alzheimer clinical trials on the motivations for and challenges of recruiting enough volunteers -- a major obstacle to progress in treatments and prevention.
• New insights into the barriers and incentives doctors face when diagnosing an individual with Alzheimer's, and the benefits of early detection of Alzheimer's.
• New research confirms the positive value of a healthy diet and moderate physical activity on cognitive performance as we age.